4.5 Article

Intraneuronal Aβ accumulation induces hippocampal neuron hyperexcitability through A-type K+ current inhibition mediated by activation of caspases and GSK-3

Journal

NEUROBIOLOGY OF AGING
Volume 36, Issue 2, Pages 886-900

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2014.10.034

Keywords

Amyloid-beta protein; Intrinsic excitability; A-type K+ current; Caspase; GSK-3; KV4.2; Alzheimer's disease; Hippocampal neurons

Funding

  1. Universita Cattolica [70200969]
  2. Alzheimer's Association [NIRG-14-321307]
  3. Institute for Translational Sciences at the University of Texas Medical Branch as part of a Clinical and Translational Science Award from the National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000071, NIH NIMH R01 MH095995]

Ask authors/readers for more resources

Amyloid beta-protein (A beta) pathologies have been linked to dysfunction of excitability in neurons of the hippocampal circuit, but the molecular mechanisms underlying this process are still poorly understood. Here, we applied whole-cell patch-clamp electrophysiology to primary hippocampal neurons and show that intracellular A beta(42) delivery leads to increased spike discharge and action potential broadening through downregulation of A-type K+ currents. Pharmacologic studies showed that caspases and glycogen synthase kinase 3 (GSK-3) activation are required for these A beta(42)-induced effects. Extracellular perfusion and subsequent internalization of A(beta 42) increase spike discharge and promote GSK-3-dependent phosphorylation of the Kv4.2 alpha-subunit, a molecular determinant of A-type K+ currents, at Ser-616. In acute hippocampal slices derived from an adult triple-transgenic Alzheimer's mouse model, characterized by endogenous intracellular accumulation of A beta(42), CA1 pyramidal neurons exhibit hyperexcitability accompanied by increased phosphorylation of Kv4.2 at Ser-616. Collectively, these data suggest that intraneuronal A beta(42) accumulation leads to an intracellular cascade culminating into caspases activation and GSK-3-dependent phosphorylation of Kv4.2 channels. These findings provide new insights into the toxic mechanisms triggered by intracellular A beta(42) and offer potentially new therapeutic targets for Alzheimer's disease treatment. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available